Effect of structural alterations on the biotransformation rate of glucocorticosteroids in rat and human liver

References

• ALBERTSSON, J., OSICARSSON, A., and SVENSSON, L., 1978, X-ray study of budesonide: molecular structures and solid solutions of the (22S) and (22R) epimers of 11/1,21-dihydroxy-16a,17apropylmethylenedioxy-1,4-pregna-diene-3,20-dione. Acta Crystalline, B34, 3027–3036.
   Web of Science ®Google Scholar
• ANDERSSON, P., BRATTSAND, R., EDSBÄCKER, S., KALLSTRifIM, L., and RYRFELDT, A., 19828, Biotransform-ation rate (in vitro) and systemic potency (in vivo) of the topical glucocorticoid budesonide in male and female rats. Journal of Steroid Biochemistry, 17, 703–706.
   Google Scholar
• ANDERSSON, P., EDSBACKER, S., RYRFELDT, A., and VON BAHR, C., 1982 b, In vitro biotransformation of glucocorticoids in liver and skin homogenate fraction from man, rat and hairless mouse. Journal of Steroid Biochemistry, 16, 787–795.
   PubMedGoogle Scholar
• BERGREM, G., Gaorrum, P., and RUGSTAD, H. E., 1983, Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration. European Journal of Clinical Pharma-cology, 24, 415–419.
   PubMed Web of Science ®Google Scholar
• BRATTSAND, R., THALÉN, A., ROEMPKE, K., KAusTRi5m, L., and ORUVSTAD, E., 1982a, Influence of 16a, 17a-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids. Journal of Steroid Biochemistry, 16, 779–786.
   Google Scholar
• BRATTSAND, R., THALÉN, A., ROEMPKE, K., KiusTRöm, L., and ORINSTAD, E., 1982 b, Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. European Journal of Respiratory Diseases, 63, (Suppl. 122), 62–73.
   PubMedGoogle Scholar
• BROWN, J. H. U., and ANASON, A., 1958, /n vitro metabolism of substituted steroids by rat liver. Endocrinology, 62, 103–107.
   PubMed Web of Science ®Google Scholar
• CHANOINE, F., and JUNIEN, J. L., 1984, Comparative pharmacokinetic studies of tixocortol pivalate and cortisol in the rat. Journal of Steroid Biochemistry, 21, 453–459.
   PubMedGoogle Scholar
• CHAPLIN, M. D., ROOKS, W., SWENSON, W., COOPER, W. C., NERENSERG, C., and CHU, N. I., 1980, Flunisolide metabolism and dynamics of a metabolite. Clinical Pharmacology and Therapeutics, 27, 402–413.
   PubMed Web of Science ®Google Scholar
• CHU, N. I., Amos, B. A., Toms, L., MADDOX, M. L., MATIN, S. B., HAMA, K. M., PATTERSON, J. W., WAGNER, P. J., BELL, J. P., and CHAPI.IN, M. D., 1979, Disposition of flunisolide in the rat, mouse, dog, rhesus monkey and cynomolgus monkey. Drug Metabolism and Disposition, 7, 81 89.
   Google Scholar
• DAVIES, D. S., 1982, Pharmacokinetic studies with inhaled drugs. European Journal of Respiratory Diseases, 63, 67–72.
   Google Scholar
• EOSBACKER, S., JöNssoN, S., LINDBERG, C., RYRFELDT, A., and THALEN, A., 1983, Metabolic pathways of the topical glucocorticoid budesonide in man. Drug Metabolism and Disposition, 11, 590–596.
   PubMed Web of Science ®Google Scholar
• ESTABROOK, R. W., MARTINEZ-ZEDILLO, G., YOUNG, S., PETERSON, J. A., and MCCARTHY, J., 1975, The interaction of steroids with liver microsomal cytochrome P-450—a general hypothesis. Journal of Steroid Biochemistry, 6, 419–425.
   Google Scholar
• KRIPALANI, K. J., COHEN, A. I., WELIKY, I., and SCHREIBER, E. C., 1975, Metabolism of triamcinolone acetonide-21-phosphate in dogs, monkeys and rats. Journal of Pharmaceutical Sciences, 64, (8), 1351–1359.
   PubMed Web of Science ®Google Scholar
• KUPFER, D., 1968, Alteration in the magnitude of tyrosin transaminase by glucocorticoids. The effects of phenobarbital, o.p. DDD and SKF 525A. Archives of Biochemistry and Biophysics, 127, 200–206.
   PubMed Web of Science ®Google Scholar
• KUPFER, D., and PARTRIDGE, R., 1970,6/3-Hydroxylation of triamcinolone acetonide by a hepatic enzyme system. Archives of Biochemistry and Biophysics, 140, 23–28.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. H., and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• NEWMAN, S. P., PAVIA, D., MORkg, F., SHEAHAN, N. F., and CLARKE, S. W., 1981, Deposition of pressurised aerosols in the human respiratory tract. Thorax, 36, (1), 52–55.
   PubMed Web of Science ®Google Scholar
• RYRFELDT, A., ANDERSSON, P., EDSBACICER, S., TONNEssoN, M., DAVIES, D., and PAUWELS, R., 1982, Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. European Journal of Respiratory Diseases, 63, (Suppl. 122), 86–95.
   Google Scholar
• SEUTTER, E., 1975, Metabolism of systemically given corticosteroids, Dermatologica, 151, 129–134.
   Google Scholar
• TEITELBAUM, P. J., CHU, N. I., CHO, D., Toles, L., PATTERSON, I. W., WAGNER, P. J., and CHAPLIN, M. D., 1981, Mechanism for the oxidative defluorination of flunisolide. Journal of Pharmacology and Experimental Therapeutics, 218, (1), 16–22.
   PubMed Web of Science ®Google Scholar
• THALEN, A., and NYLANDER, B., 1982, Epimers of budesonide and related corticosteroids. 1. Preparative resolution by chromatography on Sephadex 1.11-20. Acta Pharmaceutica Suecica, 19, 247–266.
   Google Scholar
• VON BAHR, C., GROTH, C. G., JANSSON, H., LUNDGREN, G., LIND, M., and GLAUMAN, H., 1980, Drug metabolism in human liver in vitro: establishment of a human liver bank. Clinical Pharmacology and Therapeutics, 27, 711–725.
   PubMed Web of Science ®Google Scholar
• WILLIAMS, M. H., KANE, C., and SHIM, C. S., 1974, Treatment of asthma with triamcinolone acetonide delivered by aerosol. American Review of Respiratory Diseases, 109, 538–543.
   PubMed Web of Science ®Google Scholar